OM
Opaleye Management’s Ocular Therapeutix OCUL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.8M | Hold |
1,595,000
| – | – | 3% | 9 |
|
2025
Q1 | $11.7M | Sell |
1,595,000
-2,747,500
| -63% | -$20.1M | 2.6% | 10 |
|
2024
Q4 | $37.1M | Sell |
4,342,500
-682,500
| -14% | -$5.83M | 6.49% | 5 |
|
2024
Q3 | $43.7M | Sell |
5,025,000
-282,500
| -5% | -$2.46M | 7.29% | 3 |
|
2024
Q2 | $36.3M | Sell |
5,307,500
-1,345,638
| -20% | -$9.2M | 8.29% | 3 |
|
2024
Q1 | $60.5M | Buy |
6,653,138
+583,138
| +10% | +$5.31M | 13.19% | 1 |
|
2023
Q4 | $27.1M | Sell |
6,070,000
-398,000
| -6% | -$1.78M | 7.2% | 5 |
|
2023
Q3 | $20.3M | Buy |
6,468,000
+688,000
| +12% | +$2.16M | 6.61% | 3 |
|
2023
Q2 | $29.8M | Sell |
5,780,000
-325,900
| -5% | -$1.68M | 7.13% | 3 |
|
2023
Q1 | $32.2M | Buy |
6,105,900
+30,900
| +0.5% | +$163K | 9.64% | 2 |
|
2022
Q4 | $17.1M | Sell |
6,075,000
-390,000
| -6% | -$1.1M | 5.94% | 4 |
|
2022
Q3 | $26.8M | Buy |
6,465,000
+490,200
| +8% | +$2.03M | 11.08% | 2 |
|
2022
Q2 | $24M | Hold |
5,974,800
| – | – | 10.83% | 2 |
|
2022
Q1 | $29.6M | Hold |
5,974,800
| – | – | 9.18% | 1 |
|
2021
Q4 | $41.6M | Sell |
5,974,800
-505,200
| -8% | -$3.52M | 8.83% | 2 |
|
2021
Q3 | $64.8M | Hold |
6,480,000
| – | – | 12.1% | 1 |
|
2021
Q2 | $91.9M | Hold |
6,480,000
| – | – | 15.26% | 1 |
|
2021
Q1 | $106M | Sell |
6,480,000
-30,000
| -0.5% | -$492K | 15.62% | 1 |
|
2020
Q4 | $135M | Buy |
6,510,000
+525,800
| +9% | +$10.9M | 17.6% | 1 |
|
2020
Q3 | $45.5M | Hold |
5,984,200
| – | – | 8.91% | 1 |
|
2020
Q2 | $49.8M | Buy |
5,984,200
+861,700
| +17% | +$7.18M | 10.07% | 2 |
|
2020
Q1 | $25.4M | Buy |
5,122,500
+15,000
| +0.3% | +$74.2K | 6.72% | 3 |
|
2019
Q4 | $20.2M | Buy |
5,107,500
+2,332,500
| +84% | +$9.21M | 3.96% | 7 |
|
2019
Q3 | $8.44M | Sell |
2,775,000
-175,000
| -6% | -$532K | 3.05% | 9 |
|
2019
Q2 | $13M | Buy |
2,950,000
+1,050,000
| +55% | +$4.62M | 3.96% | 7 |
|
2019
Q1 | $7.54M | Buy |
+1,900,000
| New | +$7.54M | 2.09% | 20 |
|
2018
Q4 | – | Sell |
-800,000
| Closed | -$5.5M | – | 52 |
|
2018
Q3 | $5.5M | Sell |
800,000
-311,000
| -28% | -$2.14M | 1.4% | 25 |
|
2018
Q2 | $7.5M | Hold |
1,111,000
| – | – | 1.94% | 16 |
|
2018
Q1 | $7.23M | Buy |
+1,111,000
| New | +$7.23M | 2.07% | 15 |
|
2017
Q2 | – | Sell |
-550,000
| Closed | -$5.1M | – | 47 |
|
2017
Q1 | $5.1M | Buy |
550,000
+456,400
| +488% | +$4.24M | 2.54% | 15 |
|
2016
Q4 | $783K | Buy |
+93,600
| New | +$783K | 0.46% | 37 |
|
2016
Q3 | – | Sell |
-260,000
| Closed | -$1.29M | – | 49 |
|
2016
Q2 | $1.29M | Buy |
+260,000
| New | +$1.29M | 0.86% | 40 |
|